Myelopid - instructions for use, ratings, analogs and release forms (injections in ampoules powder for solution for injection 3 mg) of the drug for treatment of infections, immune deficiencies and leukemia in adults, children and in pregnancy. Composition

In this article, you can read the instructions for using the drug Myelopid. Comments of visitors of the site - consumers of this medication, as well as opinions of doctors of specialists on the use of Myelopida in their practice are presented. A big request is to actively add their feedback on the drug: the medicine helped or did not help get rid of the disease, which were observed complications and side effects, possibly not declared by the manufacturer in the annotation. Analogues of Myelopida in the presence of existing structural analogues.Use to treat infections, immunodeficiencies and leukemia in adults, children, as well as during pregnancy and lactation. Composition of the preparation.

Myelopid - immunostimulating drug. With secondary immunodeficiency states, restores quantitative and functional indices of B- and T-systems of immunity, stimulates the functional activity of phagocytes and restores the humoral link of immunity.

Composition

Extract of bone marrow calves + auxiliary substances.

Indications

• immunodeficiency states with a predominant lesion of the humoral immunity (prevention and treatment);
• infectious complications (prophylaxis) after surgical operations, mechanical, thermal and chemical injuries;
• purulent and septic diseases;
• exacerbation of chronic infectious diseases against the background of secondary immunodeficiency;
• leukemia (as part of combination therapy).

Forms of release

Powder for solution for injection 3 mg (injections in ampoules).

Instructions for use and dosing regimen

Myelopid is administered intramuscularly. The solution is prepared ex tempore (as required). The contents of the vial are dissolved in 1-2 ml of a 0.9% solution of sodium chloride for injection.

To prevent infectious complications after operations, mechanical, thermal and chemical trauma, myelopid is administered daily at a dose of 3-6 mg (1-2 ampoules), at a rate of 0.04-0.06 mg per 1 kg of body weight 1 time per day. The course of treatment is 5 days.

For treatment of exacerbations of chronic infectious and inflammatory diseases - in the same dose every other day. The course of treatment - 3-5 injections. Application for chronic infectious diseases outside of exacerbations is irrational.

With purulent and septic processes, the contents of 1-2 ampoules (at the rate of 0.05 mg per 1 kg of body weight) are administered daily for 3 days. To increase the efficiency, an endolymphatic injection (into the lymphatic vessel on the side of the lesion) is desirable.

In the complex therapy of leukemias, myelopid is administered immediately before the start of chemotherapy course and after its termination at the rate of 0.03 mg per 1 kg of body weight of the patient.

Side effect

• soreness, tissue tightening at the injection site.

Contraindications

• hypersensitivity to the components of the drug;
• pregnancy, complicated by Rhesus-conflict;
• lactation period (breastfeeding).

Application in pregnancy and lactation

Contraindicated in the use of myelopid during pregnancy and lactation. For the duration of treatment, breastfeeding should be discontinued.

Use in children

Not indicated.

Application in elderly patients

Older patients do not need a dose reduction.

special instructions

Special instructions in the application of myelopid is not described.

Drug Interactions

Significant drug interaction in the treatment of myelopid with other drugs has not been identified.

Analogues of the drug Myelopid

Myelopid does not have structural analogs for the active substance.

Analogues of the drug Myelopid by pharmacological group (other immunomodulators):

• Aksoglatiran;
• Actinolysate;
• Actipol;
• Alkimer;
• Anaferon;
• Arbidol;
• Arpefly;
• Arthrofoon;
• Afala;
• Afludol;
• Affinoleukin;
• Bactisporin;
• Bation;
• Beast;
• Bronho Vaxom;
• BronhoMunal;
• Wartocide;
• Vilozen;
• Wobenzym;
• Galavit;
• Gepon;
• Glatyrate;
• Glutoxim;
• Groprinosin;
• Deoxynate;
• Derinat;
• Imiquimod;
• Imichimod;
• Immunal;
• Immunorm;
• Imudon;
• Imunoriks;
• Imunofan;
• Ismigen;
• Yodantipyrine;
• Keravort;
• Copaxon;
• Lycopid;
• Mozobail;
• Moliksan;
• Neuroferon;
• Neovastet;
• Nerventra;
• Optinat;
• Pyrogenal;
• Polymuramyl;
• Polyoxidonium;
• Posterizan;
• Profetal;
• Ribomunyl;
• Rhinital;
• Ruzam;
• Splenin;
• Sporobacterin;
• Stemokin;
• Tactivin;
• Tamerite;
• Timogen;
• Timusamine;
• Trekrezan;
• Tubosan;
• Ferrovir;
• Phlogenzyme;
• Helixor;
• Exalb;
• Epiphamine;
• Erbisol;
• Ergoferon;
• Estifan;
• Echinocor.

Surgeon's doctor's opinion

Immunostimulant Myelopid I repeatedly appointed patients who are on inpatient treatment in our department. They were patients with severe osteomyelitis, with purulent lesions of the skin, with post-traumatic wound infections. To some of them I added intramuscular injection of myelopid into the complex therapy. To say that the recovery of these patients was faster, in comparison with those who did not receive this drug, I can not. Therefore, my personal opinion is this: this particular immunostimulating drug does not show the effectiveness that is described by the manufacturer in the instructions.

Similar medicines:

Other medicines: